UTMD earnings date and last-quarter result: P/E 20.97. Updated 2026-07-23.
Utah Medical Products (UTMD) Research Hub
Utah Medical Products (UTMD) trades on NASDAQ, US in the Healthcare (Medical - Instruments & Supplies) sector. As of 2026-10-26, shares last closed at 73.52 USD (-0.96%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 20.97, market cap 0.22B. This hub links to the full technical, earnings and options research available for UTMD.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Instruments & Supplies) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 73.52 USD (-0.96%) |
| 52-week range | 64.77 USD – 76.89 USD |
| Trend regime | Range |
| 14-day RSI | 47.1 (Neutral) |
| Trailing P/E | 20.97 |
| Market cap | 0.22B |
| Dividend yield | 1.78% |
Available research for UTMD
Covered Call on UTMD: how it works, illustrative setup around the real 73.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on UTMD: how it works, illustrative setup around the real 73.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on UTMD: how it works, illustrative setup around the real 73.52 USD price, max profit/loss, breakeven and when to use it. Educational.
UTMD technical analysis: range, last 73.52 USD, RSI 47.1, 52w range 64.77 USD–76.89 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is UTMD in?
Utah Medical Products (UTMD) is classified under Healthcare (Medical - Instruments & Supplies), listed on NASDAQ, US.
Is UTMD in an uptrend or downtrend?
As of 2026-10-26, UTMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is UTMD's trailing P/E ratio?
UTMD's trailing P/E is 20.97, with a market cap of 0.22B. See the earnings research page for full valuation detail.